| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Causative glaucoma treatment: promising targets and delivery systems
|
Mietzner, Raphael
|
|
2019
|
24 |
8 |
p. 1606-1613
|
artikel
|
| 2 |
Challenges and opportunities for drug delivery to the posterior of the eye
|
Cabrera, Fernando J.
|
|
2019
|
24 |
8 |
p. 1679-1684
|
artikel
|
| 3 |
Combination therapy and co-delivery strategies to optimize treatment of posterior segment neurodegenerative diseases
|
Arranz-Romera, Alicia
|
|
2019
|
24 |
8 |
p. 1644-1653
|
artikel
|
| 4 |
Connexin43 hemichannels: A potential drug target for the treatment of diabetic retinopathy
|
Mugisho, Odunayo O.
|
|
2019
|
24 |
8 |
p. 1627-1636
|
artikel
|
| 5 |
Contents page 1
|
|
|
2019
|
24 |
8 |
p. i
|
artikel
|
| 6 |
Contents page 2
|
|
|
2019
|
24 |
8 |
p. ii
|
artikel
|
| 7 |
Depot formulations to sustain periocular drug delivery to the posterior eye segment
|
Agban, Yosra
|
|
2019
|
24 |
8 |
p. 1458-1469
|
artikel
|
| 8 |
Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties
|
Subrizi, Astrid
|
|
2019
|
24 |
8 |
p. 1446-1457
|
artikel
|
| 9 |
Drug delivery systems and novel formulations to improve treatment of rare corneal disease
|
Jimenez, Jorge
|
|
2019
|
24 |
8 |
p. 1564-1574
|
artikel
|
| 10 |
Drug delivery to retinal photoreceptors
|
Himawan, Erico
|
|
2019
|
24 |
8 |
p. 1637-1643
|
artikel
|
| 11 |
Emerging targets of inflammation and tear secretion in dry eye disease
|
Markoulli, Maria
|
|
2019
|
24 |
8 |
p. 1427-1432
|
artikel
|
| 12 |
Hydrogels for sustained delivery of biologics to the back of the eye
|
Chang, Debby
|
|
2019
|
24 |
8 |
p. 1470-1482
|
artikel
|
| 13 |
Intravitreal nanoparticles for retinal delivery
|
Huang, Xiaonan
|
|
2019
|
24 |
8 |
p. 1510-1523
|
artikel
|
| 14 |
Müller cells as a target for retinal therapy
|
Devoldere, Joke
|
|
2019
|
24 |
8 |
p. 1483-1498
|
artikel
|
| 15 |
Modified cells as potential ocular drug delivery systems
|
Tennikova, Tatiana
|
|
2019
|
24 |
8 |
p. 1621-1626
|
artikel
|
| 16 |
Nitric oxide: a drug target for glaucoma revisited
|
Garhöfer, Gerhard
|
|
2019
|
24 |
8 |
p. 1614-1620
|
artikel
|
| 17 |
Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development
|
Gukasyan, Hovhannes J.
|
|
2019
|
24 |
8 |
p. 1587-1597
|
artikel
|
| 18 |
Ocular drugs and drug delivery systems — Current trends and future perspectives
|
Rupenthal, Ilva D.
|
|
2019
|
24 |
8 |
p. 1425-1426
|
artikel
|
| 19 |
Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives
|
Bordet, Thierry
|
|
2019
|
24 |
8 |
p. 1685-1693
|
artikel
|
| 20 |
Physiologically based ocular pharmacokinetic modeling using computational methods
|
Missel, Paul J.
|
|
2019
|
24 |
8 |
p. 1551-1563
|
artikel
|
| 21 |
Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications
|
Soliman, Karim A.
|
|
2019
|
24 |
8 |
p. 1575-1586
|
artikel
|
| 22 |
Potential antiedematous effects of intravitreous anti-VEGF, unrelated to VEGF neutralization
|
Behar-Cohen, Francine
|
|
2019
|
24 |
8 |
p. 1436-1439
|
artikel
|
| 23 |
Protein conjugates and fusion proteins as ocular therapeutics
|
Mehta, Shrenik C.
|
|
2019
|
24 |
8 |
p. 1440-1445
|
artikel
|
| 24 |
Recent advances in intraocular sustained-release drug delivery devices
|
Cao, Yiqi
|
|
2019
|
24 |
8 |
p. 1694-1700
|
artikel
|
| 25 |
Recent advances in the management of diabetic retinopathy
|
Dulull, Nabeela
|
|
2019
|
24 |
8 |
p. 1499-1509
|
artikel
|
| 26 |
Recent developments in liposomal drug delivery systems for the treatment of retinal diseases
|
Urquhart, Andrew J.
|
|
2019
|
24 |
8 |
p. 1660-1668
|
artikel
|
| 27 |
Retinal cell regeneration using tissue engineered polymeric scaffolds
|
Abedin Zadeh, Maria
|
|
2019
|
24 |
8 |
p. 1669-1678
|
artikel
|
| 28 |
Targeting drug delivery within the suprachoroidal space
|
Jung, Jae Hwan
|
|
2019
|
24 |
8 |
p. 1654-1659
|
artikel
|
| 29 |
Targeting P2X7 receptors as a means for treating retinal disease
|
Fletcher, Erica L.
|
|
2019
|
24 |
8 |
p. 1598-1605
|
artikel
|
| 30 |
The gap between the need for novel retinal drug delivery methods, technologies in R&D phase, and approved ocular drug delivery technologies
|
Neumann, Ron
|
|
2019
|
24 |
8 |
p. 1433-1435
|
artikel
|
| 31 |
Therapeutic implications of nanomedicine for ocular drug delivery
|
Meng, Tuo
|
|
2019
|
24 |
8 |
p. 1524-1538
|
artikel
|
| 32 |
The safety evaluation of long-acting ocular delivery systems
|
Thackaberry, Evan A.
|
|
2019
|
24 |
8 |
p. 1539-1550
|
artikel
|
Tijdschrift beschrijving